Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
208,928,509
-
Total 13F shares
-
100,143,382
-
Share change
-
+9,596,626
-
Total reported value
-
$764,063,804
-
Put/Call ratio
-
73%
-
Price per share
-
$7.63
-
Number of holders
-
110
-
Value change
-
+$73,654,467
-
Number of buys
-
58
-
Number of sells
-
33
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (BCRX) as of Q3 2018
As of 30 Sep 2018,
BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (BCRX) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
100,143,382 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, LLC, BlackRock Inc., GREAT POINT PARTNERS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Vanguard Group Inc, JENNISON ASSOCIATES LLC, FMR LLC, and STATE STREET CORP.
This page lists
110
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.